| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | 1 | — | — | 1 | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 2.06 |
—
—
—
|
| 2025 | 1.96 |
—
—
—
—
|
| 2024 | 1.85 |
—
—
—
—
|
| 2023 | 1.76 |
—
—
—
—
|
| 2022 | 1.68 |
—
—
—
—
|
| 2021 | 1.60 |
—
—
—
—
|
| 2020 | 1.55 |
—
—
—
—
|
| 2019 | 1.51 |
—
—
—
—
|
| 2018 | 1.45 |
—
—
—
—
|
| 2017 | 1.75 |
—
—
—
—
—
|
| 2016 | 1.33 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 194.53 | 188.88 | 179.83 | 155.09 |
| Receivables | 444.95 | 400.13 | 417.16 | 463.60 |
| Inventory | 233.86 | 227.47 | 265.78 | 304.11 |
| Other | — | — | — | — |
| 927.89 | 876.42 | 921.19 | 991.05 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 184.81 | 198.14 | 198.93 | 234.32 |
| ST’ Debt | 23.44 | 37.55 | 35.66 | 15.65 |
| Other | — | 80.67 | 85.10 | 92.47 |
| 367.51 | 379.77 | 380.16 | 403.40 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 480.48 | 532.55 | — | — |
—
|
| ’25 | 442.91 | 483.40 | 493.84 | 468.48 |
1,888.63
|
| ’24 | 469.76 | 463.57 | 462.27 | 444.09 |
1,839.69
|
| ’23 | 500.15 | 495.44 | 490.61 | 467.11 |
1,953.31
|
| ’22 | 474.17 | 492.39 | 492.22 | 484.81 |
1,943.59
|
| ’21 | 429.78 | 435.26 | 449.07 | 447.04 |
1,761.16
|
| ’20 | 378.56 | 286.04 | 367.22 | 385.85 |
1,417.68
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 3.79 | 29.46 | — | — |
—
|
| ’25 | (3.05) | 41.57 | 51.39 | 46.54 |
136.45
|
| ’24 | 27.23 | 46.30 | 67.98 | 63.06 |
204.58
|
| ’23 | 37.78 | 78.27 | 83.41 | 79.56 |
279.02
|
| ’22 | (6.30) | (2.12) | (17.87) | 68.09 |
41.79
|
| ’21 | (12.62) | 3.05 | 12.08 | 46.42 |
48.93
|
| ’20 | 20.22 | 24.44 | 67.39 | 66.34 |
178.39
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (6.87) | 19.09 | — | — |
—
|
| ’25 | (15.38) | 33.61 | 41.04 | 21.33 |
80.60
|
| ’24 | 22.77 | 42.44 | 59.77 | 37.81 |
162.78
|
| ’23 | 31.62 | 67.39 | 74.65 | 66.55 |
240.22
|
| ’22 | (15.15) | (8.33) | (23.05) | 61.24 |
14.72
|
| ’21 | (1.81) | (14.73) | 6.23 | 37.79 |
27.48
|
| ’20 | 15.33 | 21.80 | 62.74 | 60.62 |
160.49
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.13 | 1.55 | — | — |
—
|
| ’25 | 0.73 | (3.78) | 1.75 | 1.18 |
(0.14)
|
| ’24 | 1.95 | 1.94 | 1.81 | 0.81 |
6.51
|
| ’23 | 1.64 | 1.63 | 1.87 | 1.12 |
6.26
|
| ’22 | 1.11 | 0.80 | 1.44 | (4.24) |
(0.89)
|
| ’21 | 2.15 | 1.88 | 1.73 | 1.01 |
6.77
|
| ’20 | (1.60) | (0.43) | 1.53 | 2.72 |
2.22
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 129.06 | 138.67 | 137.00 | 95.91 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 245.22 | 221.94 | 214.19 | 148.80 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,600 | 4,400 | 4,400 | 4,700 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.42 | 0.44 | 0.42 | 0.40 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,943.59 | 1,953.31 | 1,839.69 | 1,888.63 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 31.52% | 36.13% | 37.29% | 35.97% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.12 | 153.12 | 155.06 | 7.03 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.37% | 7.84% | 8.43% | 0.37% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (15.84) | 112.87 | 116.73 | (2.40) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 83.41 | 81.99 | 84.12 | 99.48 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 108.94 | 109.17 | 103.06 | 108.09 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | (0.89) | 6.27 | 6.51 | (0.14) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.34 | 15.59 | 11.46 | 7.81 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.52) | (2.17) | (2.34) | (3.20) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.83 | 13.43 | 9.12 | 4.61 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 71.67 | 77.40 | 75.86 | 78.78 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.84 | 17.89 | 17.85 | 17.47 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | 33.87 | 21.62 | 0.00 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.50 | 1.94 | 1.37 | 1.27 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.28 | 2.74 | 1.86 | 1.74 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.90 | 2.23 | 1.65 | 1.64 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 250.83 | 18.12 | 18.62 | 38.34 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 41.79 | 279.02 | 204.58 | 136.45 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (27.08) | (38.80) | (41.79) | (55.86) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.72 | 240.22 | 162.78 | 80.60 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 639.35 | 560.38 | 496.65 | 541.03 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 952.81 | 754.07 | 707.17 | 870.56 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 771.84 | 559.54 | 518.29 | 690.73 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,278.59 | 1,384.92 | 1,354.18 | 1,376.50 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.55%) | 4.07% | 4.38% | (0.09%) | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.59% | 6.89% | 6.50% | 1.60% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.19%) | 8.47% | 8.52% | (0.18%) | — | — | — |
ROE
|
Quaker Houghton (KWR), the specialty chemicals leader born from the 2019 Quaker-Houghton merger, boasts impressive revenue growth from $747 million in 2016 to $1.84 billion in 2024, yet a 6% decline last year signals brewing industrial headwinds. Projections hint at a modest rebound to $2.04 billion by 2027, but a stark net income plunge to $1.9 million in 2025—before a sharp recovery—raises questions about fragile optimism amid post-merger integration pains, including diluted employee productivity and persistent leverage from $921 million in debt.
Profitability swings wildly, with ROE recovering to 8.5% in 2024 from losses but lagging pre-merger highs, while gross margins resiliently hit 37.3% despite raw material shocks. Deleveraging has trimmed net debt 35% from peaks, yielding attractive EV/Sales at 1.6x and strong free cash flow of $167 million, yet elevated debt over 50% of equity and stagnant revenue per employee amid autos/metals slumps expose vulnerabilities.
Insiders show restraint with no sells and a modest CEO buy, supporting a hold at current multiples trading near analyst targets—but contrarians flag 2025’s earnings cliff, geopolitical risks like China’s steel woes, and macro capex cuts as storm clouds that could derail the rebound narrative.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.